Codexis (CDXS) Cash & Equivalents (2010 - 2026)
Codexis (CDXS) recorded quarterly Cash & Equivalents of $36.6 million in Q1 2026, down 28.0% quarter-over-quarter from $50.8 million in Q4 2025, and up 99.63% on a YoY basis from $18.3 million in Q1 2025.
Codexis (CDXS) Cash & Equivalents (2010 - 2026) Analysis & Trends
Codexis' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $36.6 million for Q1 2026.
- In Q1 2026, Cash & Equivalents rose 99.63% year-over-year to $36.6 million; the TTM figure through Mar 2026 stood at $36.6 million (up 99.63% YoY), while the FY2025 annual figure was $50.8 million, up 163.67% from the prior year.
- Cash & Equivalents was $36.6 million for Q1 2026 at Codexis, down from $50.8 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $114.0 million in Q4 2022 to a low of $18.3 million in Q1 2025.
- Historically, Cash & Equivalents has averaged $60.8 million across 5 years, with a median of $58.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents sank 79.81% in 2024, then jumped 163.67% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $114.0 million in 2022, then plunged by 42.87% to $65.1 million in 2023, then tumbled by 70.42% to $19.3 million in 2024, then surged by 163.67% to $50.8 million in 2025, then declined by 28.0% to $36.6 million in 2026.
- The last three Cash & Equivalents figures came in at $36.6 million (Q1 2026), $50.8 million (Q4 2025), and $25.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 558.94 Mn |
| 10 | Codexis | 226.01 Mn | 160.87 Mn | 13.18 Mn | 36.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.57 Mn |
| Dec 31, 2025 | 50.79 Mn |
| Sep 30, 2025 | 25.35 Mn |
| Jun 30, 2025 | 26.76 Mn |
| Mar 31, 2025 | 18.32 Mn |
| Dec 31, 2024 | 19.26 Mn |
| Sep 30, 2024 | 37.45 Mn |
| Jun 30, 2024 | 18.60 Mn |
| Mar 31, 2024 | 58.05 Mn |
| Dec 31, 2023 | 65.12 Mn |
| Sep 30, 2023 | 74.58 Mn |
| Jun 30, 2023 | 92.09 Mn |
| Mar 31, 2023 | 102.83 Mn |
| Dec 31, 2022 | 113.98 Mn |
| Sep 30, 2022 | 108.69 Mn |
| Jun 30, 2022 | 90.11 Mn |
| Mar 31, 2022 | 94.26 Mn |
| Dec 31, 2021 | 116.80 Mn |
| Sep 30, 2021 | 119.19 Mn |
| Jun 30, 2021 | 129.51 Mn |